A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.
Pojo M, Gonçalves CS, Xavier-Magalhães A, Oliveira AI, Gonçalves T, Correia S, Rodrigues AJ, Costa S, Pinto L, Pinto AA, Lopes JM, Reis RM, Rocha M, Sousa N, Costa BM.
Pojo M, et al. Among authors: reis rm.
Oncotarget. 2015 Apr 10;6(10):7657-74. doi: 10.18632/oncotarget.3150.
Oncotarget. 2015.
PMID: 25762636
Free PMC article.